CDC Response

Advisory Committee On Childhood Lead Poisoning Prevention (ACCLPP)

 

The current charter of the Advisory Committee on Childhood Lead Poisoning Prevention expired on October 31, 2013. The ACCLPP has provided Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services with extremely valuable scientific and technical advice related to the prevention of childhood lead poisoning.

CDC is committed to childhood lead poisoning prevention; to address this important public health concern, CDC established the Lead Poisoning Prevention Subcommittee of the NCEH/ATSDR Board of Scientific Counselors in March 2015. The subcommittee was established to provide expertise on public health policies and practices relevant to lead poisoning prevention and to conduct preparatory research, analysis, and other developmental activities involving more detailed work that cannot be practically accomplished by the full Board of Scientific Counselors.

The Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP) advises and guides the Secretary and Assistant Secretary of the U.S. Department of Health and Human Services and the Director of the Centers for Disease Control and Prevention regarding new scientific knowledge and technical developments and their practical implications for childhood lead poisoning prevention efforts.

The overall goal of the ACCLPP is to provide advice that will assist the nation in reducing the incidence and prevalence of childhood lead poisoning.

According to its charter, the ACCLPP:

  • reviews and reports regularly on childhood lead poisoning prevention practices;
  • recommends improvement in national childhood lead poisoning prevention efforts; and
  • develops written recommendations for the prevention and control of childhood lead poisoning

In making such recommendations, the ACCLPP takes into account information about the health effects of lead exposure in children, the epidemiology of childhood lead poisoning, implementation issues, ethical and legal constraints, and other factors.

 

 

 

<- Back to Blood Lead Awareness Page

<- Back to Library Archive Page

Comments are closed.